Alnylam Pharmaceuticals:CARDIO-TTRansform研究结果背后,远不止眼前所见 (NASDAQ:ALNY)
· seekingalpha.com
Alnylam Pharmaceuticals, Inc. 因对ATTR-CM的担忧而下跌。TRITON-CM仍有可能成功,下行风险得到缓冲,股票看起来被低估。点击查看ALNY最新动态。
Shares of Alnylam Pharmaceuticals, Inc. ( ALNY ) have been notably weak since my last update on this biotech, falling around 18% on worries around what the fail...